Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATP1A1 | P05023 | 16/20 | 0.89 |
| ▸ | ATP1B1 | P05026 | 16/20 | 0.89 |
| ▸ | ATP1B2 | P14415 | 16/20 | 0.89 |
| ▸ | ATP1A2 | P50993 | 16/20 | 0.89 |
| ▸ | ATP1B3 | P54709 | 16/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.89 |
| ▸ | TP53 | P04637 | 2/20 | 0.89 |
| ▸ | NPC1 | O15118 | 1/20 | 0.89 |
| ▸ | GLA | P06280 | 1/20 | 0.89 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.89 |
| ▸ | STAT3 | P40763 | 1/20 | 0.89 |
| ▸ | RECQL | P46063 | 1/20 | 0.89 |
| ▸ | RAB9A | P51151 | 1/20 | 0.89 |
| ▸ | RORC | P51449 | 1/20 | 0.89 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.89 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.89 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.89 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.89 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metildigoxin SCHEMBL2518178 | 1.00 | ATP1A1 (0.89) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Metildigoxin SCHEMBL14769389 | 1.00 | ATP1A1 (0.89) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Metildigoxin SCHEMBL12841143 | 1.00 | ATP1A1 (0.89) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Metildigoxin SCHEMBL6598684 | 0.97 | ATP1A1 (0.94) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL8200838 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL13354340 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL16144399 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL22904197 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL15959376 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 | |
| Digoxin SCHEMBL12841137 | 0.94 | ATP1A1 (1.00) | ATP1A1ATP1B1ATP1B2ATP1A2ATP1B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2565 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| WO-2024254056-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | CATALENT ONTARIO LIMITED (CA) | 2024-12-12 | — | — | WO | claimed |
| CN-119013279-A | Substituted tricyclic compounds as PARP inhibitors and uses thereof | 上海瑛派药业有限公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024112043-A1 | METHOD FOR NEUROLOGICAL SIALADENOSIS MODELING AND DRUG EFFICACY TESTING THROUGH CO-CULTURE OF HUMAN SALIVARY GLAND ORGANOIDS AND NEUROCYTOMAS | 연세대학교 산학협력단 | 2024-05-30 | — | — | WO | claimed |
| EP-3654841-B1 | TARGETED OSMOTIC LYSIS OF MALIGNANT CANCER CELLS USING PULSED MAGNETIC FIELD GRADIENTS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV (US) | 2024-02-07 | — | — | EP | claimed |
| US-20230346820-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2 | THE SCRIPPS RESEARCH INSTITUTE | 2023-11-02 | — | — | US | claimed |
| EP-4232004-A1 | FRACTAL FORMULATIONS | Nanogyre Sprl (BE) | 2023-08-30 | — | — | EP | claimed |
| US-11654292-B2 | Targeted osmotic lysis of malignant cancer cells using pulsed magnetic field gradients | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2023-05-23 | — | — | US | claimed |
| WO-2023078180-A1 | MINI-TABLET, AND PREPARATION METHOD THEREFOR AND FORMULATION THEREOF | 北京微智瑞医药科技有限公司 | 2023-05-11 | — | — | WO | claimed |
| US-20220062317-A1 | NA+/K+ ATPASE INHIBITORS FOR USE IN THE PREVENTION OR TREATMENT OF METASTASIS | UNIVERSITÄT BASEL (CH) | 2022-03-03 | — | — | US | claimed |
| US-5260066-A | Cryogel bandage containing therapeutic agent | SRCHEM INCORPORATED (US) | 1993-11-09 | — | — | US | claimed |
| US-5062959-A | Adsorption by resin | BOEHRINGER MANNHEIM GMBH (DE) | 1991-11-05 | — | — | US | claimed |
| US-4603196-A | Process for the preparation of β-methyldigoxin | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1986-07-29 | — | — | US | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| EP-0037740-B1 | SOLID MICRODOSE DRUG PREPARATION | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1985-11-21 | — | — | EP | claimed |
| EP-0093266-B1 | PROCESS FOR THE PREPARATION OF BETA-METHYL DIGOXINE | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1985-10-09 | — | — | EP | claimed |
| EP-0093266-A1 | Process for the preparation of beta-methyl digoxine | CHEMIE LINZ AKTIENGESELLSCHAFT (AT) | 1983-11-09 | — | — | EP | claimed |
| US-4380534-A | WAXES, STEROIDS, ALKALOIDS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1983-04-19 | — | — | US | claimed |
| EP-0037740-A2 | Solid microdose drug preparation | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1981-10-14 | — | — | EP | claimed |
| US-4145528-A | Process for preparing β-methyldigoxin | LEK TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) | 1979-03-20 | — | — | US | claimed |